Secukinumab in moderate to severe hidradenitis suppurativa: Week 16 results of hurley stage II and III from the sunshine and sunrise phase 3 randomized trials

被引：0
|
作者：
Kimball, Alexa B. [1 ,2 ]
Alavi, Afsaneh [3 ,4 ]
Jemec, Gregor B. E. [3 ,5 ]
Zouboulis, Christos C. [3 ,6 ,7 ,8 ,9 ,10 ]
Wozniak, Magdalena B. [11 ]
Uhlmann, Lorenz [12 ]
Llobet-Martinez, Angela [12 ]
Ravichandran, Shoba [13 ]
Marzano, Angelo V. [3 ,14 ,15 ]
Reguiai, Ziad [3 ,16 ]
机构：
[1] Harvard Med Sch, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Dermatol, Boston, MA USA
[3] European Hidradenitis Suppurat Fdn eV, Dessau, Germany
[4] Mayo Clin, Dermatol, Rochester, MN USA
[5] Zealand Univ Hosp Roskilde, Dermatol, Roskilde, Denmark
[6] Brandenburg Med Sch Theodor Fontane, Dessau, Germany
[7] Staedt Klinikum Dessau, Fac Hlth Sci Brandenburg, Dept Dermatol, Dessau, Germany
[8] Staedt Klinikum Dessau, Fac Hlth Sci Brandenburg, Dept Venereol, Dessau, Germany
[9] Staedt Klinikum Dessau, Fac Hlth Sci Brandenburg, Dept Allergol, Dessau, Germany
[10] Staedt Klinikum Dessau, Fac Hlth Sci Brandenburg, Dept Immunol, Dessau, Germany
[11] Novartis Ireland Ltd, Dublin, Ireland
[12] Novartis Pharma AG, Basel, Switzerland
[13] Novartis Pharmaceut, E Hanover, NJ USA
[14] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[15] Univ Milan, Dermatol Pathophysiol & Transplantat, Milan, Italy
[16] Polyclin Courlancy Bezannes, Dermatol, Reims, France
来源：
EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [11] International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab
    Zouboulis, Christos C.
    Prens, Errol P.
    Sayed, Christopher J.
    Molina-Leyva, Alejandro
    Bettoli, Vincenzo
    Romanelli, Marco
    Szepietowski, Jacek C.
    Martinez, Angela Llobet
    Kasparek, Torben
    Lobach, Iryna
    Wozniak, Magdalena B.
    Ortmann, Christine-Elke
    Thomas, Nicolas
    Bachhuber, Teresa
    Ravichandran, Shoba
    Tzellos, Thrasyvoulos
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (06) : e496 - e499
  • [12] Comparison of the international hidradenitis suppurativa severity scoring system (IHS4) and hurley staging in hidradenitis suppurativa disease severity assessment: A post hoc analysis of the SUNSHINE and SUNRISE phase 3 trials
    Zouboulis, Christos C.
    Prens, Errol P.
    Sayed, Christopher
    Molina-Leyva, Alejandro
    Bettoli, Vincenzo
    Romanelli, Marco
    Szepietowski, Jacek C.
    Kasparek, Torben
    Lobach, Iryna
    Wozniak, Magdalena B.
    Ortmann, Christine-Elke
    Bachhuber, Teresa
    Muscianisi, Elisa
    Ravichandran, Shoba
    Tzellos, Thrasyvoulos
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 102 - 103
  • [13] Efficacy and safety of adalimumab for moderate to severe hidradenitis suppurativa: Results from the open-label phase of a 52-week phase II, randomized, study
    Kimball, Alexa
    Williams, David
    Jemec, Gregor
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB50 - AB50
  • [14] Efficacy and safety of adalimumab in patients with moderate to severe hidradenitis suppurativa: Results from PIONEER II, a phase 3, randomized, placebo-controlled trial
    Jemec, Gregor
    Gottlieb, Alice
    Forman, Seth
    Giamarellos-Bourboulis, Evangelos
    Reguiai, Ziad
    Gu, Yihua
    Okun, Martin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB45 - AB45
  • [15] Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials
    Jemec, G. B. E.
    Okun, M. M.
    Forman, S. B.
    Gulliver, W. P. F.
    Prens, E. P.
    Mrowietz, U.
    Armstrong, A. W.
    Geng, Z.
    Gu, Y.
    Williams, D. A.
    Teixeira, H. D.
    Kimball, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (05) : 967 - 975
  • [16] The LAight® Therapy is an effective Therapeutic Option for Hurley Stage I and II Hidradenitis suppurativa: Results of the multicenter, randomized, controlled RELIEVE Study
    Schultheis, Michael
    Staubach-Renz, Petra
    Grabbe, Stephan
    Nikolakis, Georgios
    Ruckes, Christian
    von Stebut-Borschitz, Esther
    Kirschner, Uwe
    Matusiak, Lukasz
    Szepietowski, Jacek
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 33 - 33
  • [17] COVID-19 and treatment with biologics: Safety insights from the phase 3 studies of secukinumab in patients with moderate-to-severe hidradenitis suppurativa
    Muscianisi, Elisa
    Potocki, Anne-Christine
    Keefe, Deborah
    Thomas, Nicolas
    Kasparek, Torben
    Kimball, Alexa B.
    Gottlieb, Alice B.
    Alavi, Afsaneh
    Reguiai, Ziad
    Jemec, Gregor B. E.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 77 - 78
  • [18] Skin-Tissue-sparing Excision with Electrosurgical Peeling (STEEP): a surgical treatment option for severe hidradenitis suppurativa Hurley stage II/III
    Blok, J. L.
    Spoo, J. R.
    Leeman, F. W. J.
    Jonkman, M. F.
    Horvath, B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (02) : 379 - 382
  • [19] Secukinumab is effective in subjects with moderate to severe palmoplantar psoriasis: 16 week results from the GESTURE study
    Gottlieb, A.
    Sullivan, J.
    van Doorn, M.
    Kubanov, A.
    You, R.
    Hugot, S.
    Fox, T.
    Milutinovic, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 76 - 77
  • [20] Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials
    Kimball, Alexandra B.
    Sundaram, Murali
    Shields, Alan L.
    Hudgens, Stacie
    Okun, Martin
    Foley, Catherine
    Ganguli, Arijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (06) : 1141 - 1143
12345